Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation. - Test2 - elhamkhani - TriplyDB

Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.

Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.

http://www.wikidata.org/entity/Q37817621

about

Acute myeloblastic leukemia with associated BCR-ABL translocation in a dog.Atypical chronic myeloid leukemia in a German Shepherd Dog.Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy.Suspected myelodysplastic/myeloproliferative neoplasm in a feline leukemia virus-negative cat.Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dog.Demonstration of the cell clonality in canine hematopoietic tumors by X-chromosome inactivation pattern analysis.Prolyl oligopeptidase inhibitor suppresses the upregulation of ACSDKP in patients with acute myeloid leukemia.

P2860

Q33402071-5FC994D3-765F-4132-9F3E-D283D65A56C6 Q33439391-3A6CF509-69EE-4273-A0DC-ACDF45FA4FA0 Q35650512-9393D5E0-99AF-4E1A-A5F4-FB863C3B9DE5 Q41461273-426DFE22-234E-4DD3-8934-23FC811502F0 Q45331988-F6DABE75-FCA3-4A64-9900-0FC22D111B19 Q47938768-C87F8A9B-E5E0-42FB-8AC5-5D7AF12B498F Q51142054-16B31B4E-06FC-42F7-8E58-4570E32EA13A Q55196338-7FA7495E-B853-48B7-BD33-02C7B3D9E366

P2860

Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation.

http://www.wikidata.org/entity/Q37817621

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic markers for myeloid ...... oals for future investigation.

@en

Prognostic markers for myeloid ...... oals for future investigation.

@nl

type

label

Prognostic markers for myeloid ...... oals for future investigation.

@en

Prognostic markers for myeloid ...... oals for future investigation.

@nl

prefLabel

Prognostic markers for myeloid ...... oals for future investigation.

@en

Prognostic markers for myeloid ...... oals for future investigation.

@nl

P1433

Q37817621-4FDA92B3-9BD1-40DC-A8EA-C1D8BB6F5B30

P1476

Q37817621-69FF6989-2F4D-4C1C-B60C-BD2B3884DA1F

P2093

Q37817621-06EA1BC1-225F-4360-8565-2D91801D108A

Q37817621-0D5C4E55-EA6F-47D8-9EB0-E67E9B97BAC0

Q37817621-3BF4A2F4-2ECB-466F-8121-AE42543E9900

Q37817621-486FEF8D-3A9D-4959-94BE-EDA70648587B

Q37817621-D352A4F5-F516-4B40-AD6B-D099C06ABE10

Q37817621-EE7215E5-E7DC-47BB-956B-22DA813FD2D8

P2860

Q37817621-02BF1F48-6E10-40BB-A36F-04E0F76CFBFC

Q37817621-0797C4E6-B47C-4C30-9ECF-79A68A960B88

Q37817621-07D3AD37-50C7-4953-BA68-3519395130D7

Q37817621-0929FDFE-31EC-4A83-9429-8CCC55158768

Q37817621-1357BD2A-C42B-468B-91E5-CBB86F7B6937

Q37817621-13A227B8-746A-46EA-963D-8B8B1B53D4E8

Q37817621-17C59FC7-E6FF-4F39-9C4B-828FD45B8A18

Q37817621-1FC03399-FA17-44C2-8A01-361DF2C68AA7

Q37817621-21020E50-8E82-4BB3-8354-C1F0441B4488

Q37817621-240D14EB-82A7-4C0E-AA6E-95F598438244

P304

Q37817621-4A669629-14CA-4FD0-ADDC-65D43E4B91F0

P31

Q37817621-316A5C30-7AEE-44DA-BA51-4C33F4D27BF7

Q37817621-886e0378-ffb3-4724-97da-b790f5e6671c

P356

Q37817621-D89F97D2-37CF-4DD6-AD45-D34F64ACBA6F

P433

Q37817621-6026D2B1-2C94-4BA3-90C7-E4C32C0898D8

P478

Q37817621-95E09496-3705-4618-AA9E-0DDBEACA5E1A

P577

Q37817621-43398340-2B7E-4DDA-8B67-7BD9A19A98E9

P5875

Q37817621-5BDC251C-72E7-47AE-9F21-5080B4C39949

P698

Q37817621-1506F73C-E185-4A03-B5FF-3D647381929D

P356

0300985810389317

P1433

Veterinary Pathology

P1476

Prognostic markers for myeloid ...... oals for future investigation.

@en

P2093

D Bienzle

http://www.w3.org/2001/XMLSchema#string

D C Bernreuter

http://www.w3.org/2001/XMLSchema#string

M A Thrall

http://www.w3.org/2001/XMLSchema#string

P M McManus

http://www.w3.org/2001/XMLSchema#string

T A Juopperi

http://www.w3.org/2001/XMLSchema#string

W Vernau

http://www.w3.org/2001/XMLSchema#string

P2860

Genome sequence, comparative analysis and haplotype structure of the domestic dog

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

The World Health Organization (WHO) classification of the myeloid neoplasms

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia

P304

182-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0300985810389317

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49665459

http://www.w3.org/2001/XMLSchema#string

P698

21139142

http://www.w3.org/2001/XMLSchema#string